General Information of Drug (ID: DMZDW16)

Drug Name
ETI-210
Indication
Disease Entry ICD 11 Status REF
Lymphoma 2A80-2A86 Investigative [1]
Cross-matching ID
TTD ID
D0EO3K

References

1 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.